Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/19786
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Grebely, J. | - |
dc.contributor.author | Dalgard, O. | - |
dc.contributor.author | Conway, B. | - |
dc.contributor.author | Foster, G. | - |
dc.contributor.author | Bruggmann, P. | - |
dc.contributor.author | Backmund, M. | - |
dc.contributor.author | ROBAEYS, Geert | - |
dc.contributor.author | Swan, T. | - |
dc.contributor.author | Hajarizadeh, B. | - |
dc.contributor.author | Amin, J. | - |
dc.contributor.author | Marks, P. | - |
dc.contributor.author | Quiene, S. | - |
dc.contributor.author | Weltman, M. | - |
dc.contributor.author | Shaw, D. | - |
dc.contributor.author | Dunlop, A. | - |
dc.contributor.author | Hellard, M. | - |
dc.contributor.author | Bruneau, J. | - |
dc.contributor.author | Bourgeois, S. | - |
dc.contributor.author | Thurnheer, C. | - |
dc.contributor.author | Dore, G. J. | - |
dc.date.accessioned | 2015-11-18T14:33:30Z | - |
dc.date.available | 2015-11-18T14:33:30Z | - |
dc.date.issued | 2015 | - |
dc.identifier.citation | JOURNAL OF HEPATOLOGY, 62 (S2), p. S657-S657 | - |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.uri | http://hdl.handle.net/1942/19786 | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCIENCE BV | - |
dc.title | Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCD genotype 2/3 infection: the activate study | - |
dc.type | Journal Contribution | - |
local.bibliographicCitation.conferencedate | APR 22-26, 2015 | - |
local.bibliographicCitation.conferencename | 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver | - |
local.bibliographicCitation.conferenceplace | Vienna, AUSTRIA | - |
dc.identifier.epage | S657 | - |
dc.identifier.issue | S2 | - |
dc.identifier.spage | S657 | - |
dc.identifier.volume | 62 | - |
local.format.pages | 1 | - |
local.bibliographicCitation.jcat | M | - |
dc.description.notes | [Grebely, J.; Hajarizadeh, B.; Amin, J.; Marks, P.; Quiene, S.; Dore, G. J.] UNSW Australia, Kirby Inst, Sydney, NSW, Australia. [Dalgard, O.] Akershus Univ Hosp, Oslo, Norway. [Conway, B.] Vancouver Infect Dis Ctr, Vancouver, BC, Canada. [Foster, G.] Queen Marys Univ London, Liver Unit, London, England. [Bruggmann, P.] Arud Ctr Addict Med, Zurich, Switzerland. [Backmund, M.] Univ Munich, Munich, Germany. [Robaeys, G.] Ziekenhuis Oost Limburg, Dept Gastroenterol & Hepatol, Genk, Belgium. [Robaeys, G.] UZLeuven, Dept Hepatol, Leuven, Belgium. [Robaeys, G.] UHasselt, Hasselt, Belgium. [Swan, T.] Treatment Act Grp, New York, NY USA. [Weltman, M.] Nepean Hosp, Sydney, NSW, Australia. [Shaw, D.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia. [Dunlop, A.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia. [Hellard, M.] Burnet Inst, Melbourne, Vic, Australia. [Bruneau, J.] Univ Montreal, Montreal, PQ, Canada. [Bourgeois, S.] Stuivenberg ZNA, Antwerp, Belgium. [Thurnheer, C.] Univ Hosp Bern, Div Infect Dis, CH-3010 Bern, Switzerland. [Thurnheer, C.] Univ Bern, Bern, Switzerland. | - |
local.publisher.place | AMSTERDAM | - |
local.type.refereed | Refereed | - |
local.type.specified | Meeting Abstract | - |
dc.identifier.isi | 000362830900043 | - |
item.contributor | Grebely, J. | - |
item.contributor | Dalgard, O. | - |
item.contributor | Conway, B. | - |
item.contributor | Foster, G. | - |
item.contributor | Bruggmann, P. | - |
item.contributor | Backmund, M. | - |
item.contributor | ROBAEYS, Geert | - |
item.contributor | Swan, T. | - |
item.contributor | Hajarizadeh, B. | - |
item.contributor | Amin, J. | - |
item.contributor | Marks, P. | - |
item.contributor | Quiene, S. | - |
item.contributor | Weltman, M. | - |
item.contributor | Shaw, D. | - |
item.contributor | Dunlop, A. | - |
item.contributor | Hellard, M. | - |
item.contributor | Bruneau, J. | - |
item.contributor | Bourgeois, S. | - |
item.contributor | Thurnheer, C. | - |
item.contributor | Dore, G. J. | - |
item.accessRights | Restricted Access | - |
item.fullcitation | Grebely, J.; Dalgard, O.; Conway, B.; Foster, G.; Bruggmann, P.; Backmund, M.; ROBAEYS, Geert; Swan, T.; Hajarizadeh, B.; Amin, J.; Marks, P.; Quiene, S.; Weltman, M.; Shaw, D.; Dunlop, A.; Hellard, M.; Bruneau, J.; Bourgeois, S.; Thurnheer, C. & Dore, G. J. (2015) Efficacy of response-guided pegylated interferon and ribavirin therapy for people who inject drugs with HCD genotype 2/3 infection: the activate study. In: JOURNAL OF HEPATOLOGY, 62 (S2), p. S657-S657. | - |
item.fulltext | With Fulltext | - |
crisitem.journal.issn | 0168-8278 | - |
crisitem.journal.eissn | 1600-0641 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
grebely 2.pdf Restricted Access | Published version | 38.65 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.